← Forte Biosciences
What podcasts say about Forte Biosciences
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Forte Biosciences
3 statements · 3 positive
Organics agreed to acquire Forte Biosciences for $77 per share, valuing equity at about $2.2 billion.
“this one also some outperformance jumping about 40% after Organics agreed to acquire the biotech at $77 a share in cash representing a total equity value of about 2.2 billion.”
Open the episode · Closing Bell: Meatpackers Gain, Nvidia Drops, Fertilizer Names FallListen at 2:36
Forte Biosciences reported positive early-stage clinical data for its vitiligo drug.
“reporting some pretty positive early stage clinical data for its Vitiligo drug”
Open the episode · Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences SoarsListen at 2:42
Forte Biosciences’ clinical data lifted peers including First Tracks Biotherapeutics.
“it also pushed up some of its peers as well, like First Tracks Biotherapeutics, which is pursuing a similar molecule for a different therapy area”
Open the episode · Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences SoarsListen at 2:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.